Capital City Trust Co. FL Has $210,000 Stake in MetLife, Inc. (NYSE:MET)

Capital City Trust Co. FL boosted its position in shares of MetLife, Inc. (NYSE:METGet Rating) by 12.0% in the second quarter, Holdings Channel reports. The fund owned 3,352 shares of the financial services provider’s stock after acquiring an additional 360 shares during the period. Capital City Trust Co. FL’s holdings in MetLife were worth $210,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of MET. Carolinas Wealth Consulting LLC grew its stake in MetLife by 26.4% during the first quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider’s stock worth $54,000 after buying an additional 160 shares during the last quarter. Windsor Capital Management LLC grew its stake in MetLife by 1.4% during the first quarter. Windsor Capital Management LLC now owns 11,437 shares of the financial services provider’s stock worth $803,000 after buying an additional 161 shares during the last quarter. Woodward Diversified Capital LLC grew its stake in MetLife by 1.9% during the first quarter. Woodward Diversified Capital LLC now owns 9,209 shares of the financial services provider’s stock worth $647,000 after buying an additional 171 shares during the last quarter. DAVENPORT & Co LLC grew its stake in MetLife by 0.5% during the first quarter. DAVENPORT & Co LLC now owns 36,806 shares of the financial services provider’s stock worth $2,587,000 after buying an additional 177 shares during the last quarter. Finally, Boenning & Scattergood Inc. grew its stake in MetLife by 1.8% during the first quarter. Boenning & Scattergood Inc. now owns 10,210 shares of the financial services provider’s stock worth $718,000 after buying an additional 183 shares during the last quarter. Institutional investors and hedge funds own 86.53% of the company’s stock.

Analysts Set New Price Targets

MET has been the topic of several research analyst reports. Morgan Stanley increased their price target on shares of MetLife from $79.00 to $83.00 and gave the company an “overweight” rating in a research note on Wednesday, August 17th. Wolfe Research raised shares of MetLife from a “market perform” rating to an “outperform” rating and increased their price target for the company from $70.00 to $74.00 in a research note on Wednesday, June 22nd. Raymond James initiated coverage on shares of MetLife in a research note on Wednesday. They set a “market perform” rating on the stock. JPMorgan Chase & Co. decreased their price target on shares of MetLife from $75.00 to $74.00 in a research note on Monday, July 11th. Finally, Credit Suisse Group increased their price target on shares of MetLife from $68.00 to $77.00 and gave the company an “outperform” rating in a research note on Monday, August 22nd. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $76.92.

Insider Transactions at MetLife

In other news, EVP Steven J. Goulart sold 4,060 shares of the stock in a transaction on Friday, August 19th. The shares were sold at an average price of $67.60, for a total transaction of $274,456.00. Following the completion of the sale, the executive vice president now owns 55,299 shares of the company’s stock, valued at $3,738,212.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.26% of the stock is owned by insiders.

MetLife Trading Down 1.9 %

MET opened at $62.25 on Friday. The firm’s fifty day moving average is $64.62 and its two-hundred day moving average is $65.60. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.13 and a current ratio of 0.13. The firm has a market cap of $50.62 billion, a PE ratio of 15.79, a price-to-earnings-growth ratio of 0.48 and a beta of 1.05. MetLife, Inc. has a twelve month low of $57.05 and a twelve month high of $73.18.

MetLife (NYSE:METGet Rating) last posted its earnings results on Wednesday, August 3rd. The financial services provider reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.45. The company had revenue of $18.30 billion for the quarter, compared to analyst estimates of $16.53 billion. MetLife had a net margin of 5.26% and a return on equity of 12.90%. Equities research analysts anticipate that MetLife, Inc. will post 7.36 EPS for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Tuesday, August 9th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.21%. The ex-dividend date of this dividend was Monday, August 8th. MetLife’s dividend payout ratio is 49.75%.

MetLife Company Profile

(Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METGet Rating).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.